Literature DB >> 9193222

Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas. Identification of 2 regions of loss--18q11.1-q12.3 and 18q21.1-q23.

J W Jones1, J R Raval, T F Beals, M J Worsham, D L Van Dyke, R M Esclamado, G T Wolf, C R Bradford, T Miller, T E Carey.   

Abstract

OBJECTIVES: To determine the frequency and regions of loss on chromosome arm 18q in uncultured head and neck squamous cell carcinomas.
DESIGN: Polymerase chain reaction amplification of DNA extracted from 18 tumor specimens (1 patient had 2 tumors) and blood samples from 17 patients with head and neck squamous cell carcinoma was performed using primers flanking 16 microsatellite repeat polymorphisms spanning most of chromosome 18q. DNA was extracted only from specimens with greater than 70% tumor nuclei.
SETTING: Research university. PATIENTS: Seventeen individuals with newly diagnosed head and neck cancer. MAIN OUTCOME MEASURE: Loss of heterozygosity (LOH).
RESULTS: There was LOH at more than 1 locus in 52% (9/ 17) of the tumors; 3 tumors had LOH at all informative markers. Four had loss at only 1 locus, raising the total with loss to 12 (75%) of 16. Loss of 18q11.1-q12.3 in 4 tumors without distal loss defines a proximal region of loss. Loss of heterozygosity affecting 18q21.1 in 1 tumor, without proximal loss and LOH for 18q21.1, 18q22, or 18q23 in 9 (52%) of 17 tumors defines a distal region of loss.
CONCLUSIONS: Loss of heterozygosity on chromosome arm 18q is not an artifact of in vitro culture. The finding of 18q LOH in 50% to 70% tumors makes 18q an important region for study. Regions 18q11.1-q12.3 and 18q21.1-q23 are common regions of loss, indicating that there may be more than one 18q tumor suppressor gene involved in the genesis and progression of head and neck squamous cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9193222     DOI: 10.1001/archotol.1997.01900060052009

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  6 in total

1.  Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization.

Authors:  R G Weber; M Scheer; I A Born; S Joos; J M Cobbers; C Hofele; G Reifenberger; J E Zöller; P Lichter
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

2.  The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.

Authors:  Megan L Ludwig; Aditi Kulkarni; Andrew C Birkeland; Nicole L Michmerhuizen; Susan K Foltin; Jacqueline E Mann; Rebecca C Hoesli; Samantha N Devenport; Brittany M Jewell; Andrew G Shuman; Matthew E Spector; Thomas E Carey; Hui Jiang; J Chad Brenner
Journal:  Oral Oncol       Date:  2018-11-08       Impact factor: 5.337

3.  Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines.

Authors:  J Chad Brenner; Martin P Graham; Bhavna Kumar; Lindsay M Saunders; Robbi Kupfer; Robert H Lyons; Carol R Bradford; Thomas E Carey
Journal:  Head Neck       Date:  2010-04       Impact factor: 3.147

4.  GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model.

Authors:  Deepak Kamnasaran; Baoping Qian; Cynthia Hawkins; William L Stanford; Abhijit Guha
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

5.  GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer.

Authors:  Yoshimitsu Akiyama; Neil Watkins; Hiromu Suzuki; Kam-Wing Jair; Manon van Engeland; Manel Esteller; Hidekazu Sakai; Chun-Yan Ren; Yasuhito Yuasa; James G Herman; Stephen B Baylin
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

Review 6.  Animal models to study the mutational landscape for oral cavity and oropharyngeal cancers.

Authors:  Michael T Spiotto; Matthew Pytynia; Gene-Fu F Liu; Mark C Ranck; Ryan Widau
Journal:  J Oral Maxillofac Res       Date:  2013-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.